Cleary joins Restore as the company accelerates its clinical pathway toward advanced US studies

OR YEHUDA, Israel, Nov. 26, 2025 /PRNewswire/ -- Restore Medical Ltd., a privately held medical device company developing a novel transcatheter therapy for heart failure, today announced the appointment of Chris Cleary, former Senior Vice President of Corporate Development at Medtronic, as Chairman of its Board of Directors.

Restore Medical is advancing a proprietary, minimally invasive therapy designed to treat patients suffering from heart failure with reduced ejection fraction (HFrEF). With encouraging early clinical results, the company is now preparing for the next phase of its clinical development, strengthening its leadership team to support global expansion and upcoming US study.

Clea

See Full Page